Executive director

BioCentriq® Expands its Executive Leadership Team with Appointment of Jennifer Manning as Chief Commercial Officer

Retrieved on: 
Tuesday, October 3, 2023

NEWARK, N.J., Oct. 3, 2023 /PRNewswire/ -- BioCentriq, a cell therapy CDMO (contract development and manufacturing organization), announced today the appointment of Jennifer Manning, MPA, as its Chief Commercial Officer, effective October 3, 2023.

Key Points: 
  • NEWARK, N.J., Oct. 3, 2023 /PRNewswire/ -- BioCentriq, a cell therapy CDMO (contract development and manufacturing organization), announced today the appointment of Jennifer Manning, MPA, as its Chief Commercial Officer, effective October 3, 2023.
  • Ms. Manning added, "I am honored and excited to join the BioCentriq leadership team.
  • Before joining CBM, she held the position of Executive Director, Commercial Development at Fujifilm Diosynth Biotechnologies, where she was responsible for building and leading the North American Advanced Therapies commercial development team.
  • Earlier in her career, Ms. Manning held commercial roles of increasing responsibility at Lonza, Alcami Corporation, Patheon, and DSM Biologics.

Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder

Retrieved on: 
Thursday, September 28, 2023

CHARLOTTESVILLE, Va., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that on October 4, 2023, at 2:15 p.m. Eastern Time, it will be hosting a LinkedIn Live Key Opinion Leader (KOL) webinar to discuss AUD, the current treatment landscape, and the need for non-abstinence-based therapeutics.

Key Points: 
  • The webinar will be a panel discussion between leading experts in the addiction field - Joseph Volpicelli, M.D., Ph.D, and Jonathan Hunt-Glassman, MBA - and moderated by Brookline Capital Senior Analyst and Director of Research, Kemp Dolliver.
  • Dr. Volpicelli is the Executive Director and founder of the Volpicelli Center for Addiction.
  • Dr. Volpicelli is a featured author of over 100 academic publications and two of his own books on addiction treatment.
  • He has over 17 years of experience in the healthcare industry, including UnitedHealth and Humana.

WFIS to facilitate Indonesia's most disruptive integration of Technology & FSI

Retrieved on: 
Wednesday, September 27, 2023

In the wake of the situation, the world's largest archipelago is propelling forward with its digital economy and has already produced multiple fintech unicorns.

Key Points: 
  • In the wake of the situation, the world's largest archipelago is propelling forward with its digital economy and has already produced multiple fintech unicorns.
  • The latter has even launched "Master Plan for the Indonesian Financial Services Sector (MPSJKI) 2021-2025" to further favor the developments.
  • With all major financial institutions looking to upgrade their structure with added digital offerings, Indonesia has now become a utopia for technology vendors.
  • This is where WFIS comes across as the best fit for bridging the gap between financial institutions and technology organizations.

PRIM&R Announces New Executive Director

Retrieved on: 
Wednesday, September 20, 2023

“After an extensive search and careful consideration, I am thrilled to announce that Ivy Tillman has accepted the position of Executive Director.

Key Points: 
  • “After an extensive search and careful consideration, I am thrilled to announce that Ivy Tillman has accepted the position of Executive Director.
  • “I am honored to take on the role of Executive Director and work with PRIM&R’s dedicated staff.
  • Elisa A. Hurley, PhD, the second Executive Director since PRIM&R’s founding in 1974, stepped down on August 18 after leading the nonprofit for nine years.
  • Dr. Hurley described her tenure leading PRIM&R as “wonderful, challenging, fulfilling.”
    Dr. Tillman will officially begin her role as PRIM&R’s Executive Director on October 16.

PHAXIAM Therapeutics announces the completion of its reverse share split

Retrieved on: 
Monday, September 18, 2023

The main features of this reverse share split, as detailed in the notice of reverse share split published in the Bulletin des Annonces Légales Obligatoires (BALO) on July 31st, 2023 and in the press release published by the Company on July 27th, 2023, are as follows:

Key Points: 
  • The main features of this reverse share split, as detailed in the notice of reverse share split published in the Bulletin des Annonces Légales Obligatoires (BALO) on July 31st, 2023 and in the press release published by the Company on July 27th, 2023, are as follows:
    Number of Existing Shares subject to the reverse share split: sixty million seven hundred and fifty-one thousand and fifty-four (60,751,054) shares, each with a par value of ten euro cents (€0.10).
  • Number of New Shares resulting from the reverse share split: six million seventy-five thousand one hundred and five (6,075,105) shares with a par value of one euro (€1) each.
  • In connection with the reverse share split described above, The Bank of New York Mellon (“BNY Mellon”), depositary for the Company’s American Depositary Receipt (“ADR”) program, will effect a reverse stock split on such ADR program with an effective date of September 18, 2023.
  • BNY Mellon will attempt to sell any fractions and distribute the cash proceeds to ADR holders.

Paris International Children's Art Festival Unites Creativity and Dreams at the Eiffel Tower

Retrieved on: 
Thursday, September 14, 2023

The Eiffel Tower served as the venue for the second Paris International Children's Art Festival (PICAF).

Key Points: 
  • The Eiffel Tower served as the venue for the second Paris International Children's Art Festival (PICAF).
  • Our platform seeks to promote fair and widespread dissemination and sharing of art education resources, ensuring that every child has the opportunity to receive art education.
  • In addition, the art festival featured interactive zones and an exhibition area for outstanding artworks, allowing children to unleash their energy and creativity.
  • Anticipation is already building for the next edition of the festival, where children's dreams will once again take center stage on the art platform!

Understanding CMGE's (0302.HK) Path to Stable Growth from its Mid-term Report

Retrieved on: 
Monday, September 4, 2023

The monthly average number of paid users and the monthly average revenue per paid user (ARPPU) also realized a year-on-year growth of more than 20%.

Key Points: 
  • The monthly average number of paid users and the monthly average revenue per paid user (ARPPU) also realized a year-on-year growth of more than 20%.
  • It is worth noting that the cost reduction and efficiency enhancement measures of CMGE have achieved new results continuously.
  • In fact, in terms of a long term, CMGE has always been maintaining a stable rhythm, and its uniqueness lies in the stability.
  • Looking ahead to the second half of the year, CMGE still shows a trend of high certainty and steady growth.

The Industrial Designers Society of America (IDSA) Appoints New Executive Director

Retrieved on: 
Thursday, August 10, 2023

HERNDON, Va., Aug. 10, 2023 /PRNewswire/ -- The Industrial Designers Society of America (IDSA), one of the world's leading Industrial Design organizations, is pleased to announce the appointment of Donté P. Shannon, FASAE, CAE, as its Executive Director. Donté brings extensive experience in association management and unparalleled leadership skills to the role of Executive Director.

Key Points: 
  • HERNDON, Va., Aug. 10, 2023 /PRNewswire/ -- The Industrial Designers Society of America (IDSA), one of the world's leading Industrial Design organizations, is pleased to announce the appointment of Donté P. Shannon, FASAE, CAE, as its Executive Director.
  • Donté brings extensive experience in association management and unparalleled leadership skills to the role of Executive Director.
  • Donté has 18 years of experience as an association executive and board strategy advisor, including over seven years as a chief executive officer.
  • As the new Executive Director, Donté will lead IDSA's strategic direction, manage its operational priorities, and enhance its delivery of exceptional products and services.

Elcora Provides Status Update on Management Cease Trade Order and Filing of Annual Financial Statements

Retrieved on: 
Thursday, August 10, 2023

HALIFAX, Nova Scotia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the "Company" or "Elcora"), provides an update with respect to the previously announced Management Cease Trade Order (the "MCTO") that was issued by the Nova Scotia Securities Commission (the “Commission”) on August 1, 2023.

Key Points: 
  • HALIFAX, Nova Scotia, Aug. 09, 2023 (GLOBE NEWSWIRE) -- ELCORA ADVANCED MATERIALS CORP. (TSX.V:ERA | Frankfurt:ELM | OTCQB – ECORF), (the "Company" or "Elcora"), provides an update with respect to the previously announced Management Cease Trade Order (the "MCTO") that was issued by the Nova Scotia Securities Commission (the “Commission”) on August 1, 2023.
  • The Company confirms that as of today it has completed and filed its audited annual financial statements for the year ended March 31, 2023, and the management's discussion and analysis and related CEO and CFO certificates for the period which were required to be filed on or before July 31, 2023.
  • The MCTO will remain in effect until the Commission’s Executive Director (the “Executive Director”) has revoked the MCTO.
  • The Company’s CEO, CFO, and directors will continue to cease in trading of the Company’s securities until two full business days has passed following the receipt by the Commission of all filings the Company is required to make under Nova Scotia securities laws, or further order of the Executive Director.

Quanterix Appoints Vandana Sriram as Chief Financial Officer

Retrieved on: 
Wednesday, August 9, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it has appointed Vandana Sriram, CPA, as Chief Financial Officer (CFO), effective August 21, 2023.

Key Points: 
  • Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it has appointed Vandana Sriram, CPA, as Chief Financial Officer (CFO), effective August 21, 2023.
  • “Vandana is experienced in developing and executing strategic roadmaps and financial plans to foster growth opportunities,” said Masoud Toloue, CEO at Quanterix.
  • While there, she led overall financial planning and drove simplification of financial processes and operating rhythms during a highly dynamic COVID downturn period.
  • Sriram also graduated from the GE Experience Financial Leadership Program and is a registered CPA.